Bocunebart, a novel anti-PACAP antibody, targets a distinct neurological pathway from existing CGRP therapies.
Johan Lutman
Advertisement
Articles by Johan Lutman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Beyond Weight Loss: Exploring the Renal and Anti-Inflammatory Benefits of High-Dose Semaglutide
4
Adults With Schizophrenia Remain Stable When Transitioning from Atypical Antipsychotic to Cobenfy
5